Combination therapy will be subject of Phase I/Ib study set to start in the second half of this year
Researchers develop novel technique to induce a specific type of cell death in brain cancer cells from mice
$70 million deal covers the E.U, as well as Iceland, Norway, Switzerland and Liechtenstein.
Company eliminates 26 jobs, leaving it with 105 employees, after lead product Brincidofovir misses primary endpoint
Collaboration could generate up to $855M-plus for Exelixis, two years after the failure of a Phase III trial of the treatment in prostate cancer
Researchers recently published the results of testing a Plasmodium vivax malaria vaccine candidate in a human challenge model.
Bacteria engineered in Japan yield 300 times more opiates than yeast
Termination follows the disclosure in July that epratuzumab failed two Phase III trials in systemic lupus erythematosus
https://youtu.be/TBGG8e4EVts Broadcast Date: February 23rd, 2016Time: 11:00 am ET, 8:00 am PT The use of human cells as therapeutic interventions is a revolution for biomedical science. Cell therapies...